MARTIN FAKIEL: Open Payments
NPI 1972787000 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 5 payments from 4 companies in 2025. Trend: 2023 $1,061 · 2024 $551 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $245 |
| Neurocrine BioSciences, Inc. | 1 | $168 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Alkermes, Inc. | 1 | $118 |
Products named: REXULTI, UZEDY, LYBALVI.
Industry payments across NV — which companies pay providers there.
